First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 67.63 USD 0.93%
Updated: May 16, 2024

Gilead Sciences Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gilead Sciences Inc
Gross Profit Peer Comparison

Comparables:
ABBV
AMGN
MRNA
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$20.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Moderna Inc
NASDAQ:MRNA
Gross Profit
$1.2B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.6B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is Gilead Sciences Inc's Gross Profit?
Gross Profit
20.8B USD

Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Gross Profit amounts to 20.8B USD.

What is Gilead Sciences Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
7%

Over the last year, the Gross Profit growth was -3%.